News

Single-dose CAR-T therapy potentially curative in multiple myeloma
A multi-institutional study led by the Icahn School of Medicine at Mount Sinai reports one-third of patients with relapsed or ...
CURE44m
KITE-363 Shows High Response in B-Cell Lymphoma With Manageable Safety
The dual-targeting CAR T-cell therapy KITE-363 showed positive response rates and manageable side effects in relapsed or ...